Medicine and Dentistry
Liver Transplantation
99%
Transplantation
56%
Liver Graft
47%
Hepatocellular Carcinoma
40%
Kidney Graft
34%
Living Donors
32%
Kidney Transplantation
29%
Graft Survival
28%
Immunosuppressive Treatment
25%
Human Immunodeficiency Virus
23%
Allograft
20%
Neoplasm
19%
Belatacept
17%
Pediatrics
16%
Nephrectomy
15%
COVID-19
14%
Surgery
13%
Graft Failure
13%
Intestinal Transplantation
12%
Hepatectomy
12%
Recurrent Disease
11%
Cyclosporine
11%
Hazard Ratio
9%
Milan Criteria
9%
Organ Transplantation
8%
Hepatitis C
8%
Infection
8%
Liver Disease
8%
Survival Rate
8%
Hepatitis C Virus
8%
Creatinine
7%
Acute Graft Rejection
7%
Biopsy Technique
7%
Cholangiocarcinoma
7%
Body Mass Index
7%
Ischemia
7%
Overall Survival
7%
Liver Cirrhosis
7%
Tacrolimus
6%
Hepatic Portal Vein
6%
Rapamycin
6%
Odds Ratio
6%
Common Hepatic Artery
6%
Machine Perfusion
6%
End Stage Renal Disease
5%
Renal Protection
5%
Lymphocyte
5%
Bilirubin
5%
Hepatitis B Virus
5%
Disease
5%
Keyphrases
Liver Transplantation
100%
Hepatocellular Carcinoma
46%
Liver Transplant Recipients
34%
Transplantation
33%
Liver
29%
Kidney Transplant Recipients
25%
Graft Survival
21%
Kidney Transplantation
21%
Belatacept
19%
Immunosuppression
19%
Living Donor
16%
United States
14%
Orthotopic Liver Transplantation
14%
Living Donor Liver Transplantation
14%
Donor Nephrectomy
13%
Intestinal Transplantation
13%
Donor Kidney
13%
Kidney Transplant
13%
Pretransplant
13%
COVID-19
13%
Tacrolimus
12%
Cyclosporine
12%
Hepatitis C Virus
12%
Patient Survival
12%
Hazard Ratio
11%
Kidney
11%
Tumor
11%
Milan Criteria
10%
Confidence Interval
10%
Hepatitis C
10%
Transplant Recipients
9%
Resection
9%
AIDS/HIV
9%
Graft Loss
9%
Extended Criteria Donor
9%
Deceased Donor
9%
Single Center
9%
Graft Failure
8%
HIV-positive
8%
Living Liver Donor
8%
Post-liver Transplantation
8%
Single-center Experience
8%
Right Lobe
7%
Living Donation
7%
Donation after Circulatory Death
7%
Pediatric Liver Transplant
7%
African American
7%
Liver Allograft
7%
Underutilization
6%
Sirolimus
6%